Company search
Investment trusts: the treatments and takeovers behind the biotech boom
From cancer to depression, new medicines will transform health outcomes.
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Research
Please note that this research may have been paid for by the investment company. Any opinions and ratings are not endorsed by the AIC.
Kepler Trust Intelligence
11 March 2026
BIOG has soared as biotechnology has come back into favour.
Related articles
Longest serving investment trust managers on lessons learned from investing through conflicts and crises
“Stay calm and keep things in perspective”.
Commodities take gold in 2025 performance tables with 44% return
China comes in second, shrugging off trade war worries.
M&A activity drives momentum in biotech and healthcare
“The buying has not stopped” as excitement over weight loss drugs continues.
Related videos
The Biotech Growth Trust: why now for global biotech innovation?
Geoff Hsu explains how Biotech Growth Trust provides access to innovation across biotech, from new medicines to global opportunities.
Biotechnology & Healthcare: what are the challenges of investing in the sector?
Annabel Brodie-Smith asks managers about the challenges of investing in the Biotechnology & Healthcare sector.
Biotechnology & Healthcare: where are you finding opportunities?
A panel of Biotechnology & Healthcare managers discuss where they are currently finding opportunities.
Biotechnology & Healthcare: is the sector due a comeback?
Annabel Brodie-Smith, Brett Darke, Marek Poszepczynski and Geoff Hsu discuss whether Biotechnology & Healthcare is due a comeback.
Related industry news
Sven Borho steps down from Worldwide Healthcare Trust
Sven Borho has stepped down as lead portfolio manager of Worldwide Healthcare Trust (LON:WWH) with immediate effect. Borho was a founder of the trust’s New York-based manager OrbiMed Capital.
Sven Borho steps down from Worldwide Health with Biotech Growth’s Hsu becoming co-manager
Worldwide Healthcare Trust (WWH) fund manager Sven Borho has stepped down with immediate effect. The OrbiMed partner, who helps lead the New York firm...
Biotech Growth Trust boosted by Forte Biosciences buyout
Investment trust Biotech Growth (LON:BIOG) received another boost after Forte Biosciences (NASDAQ:FBRX) agreed a $2.2 billion takeover by Argenx (EBR:ARGX), a Belgian-Dutch pharmaceutical company.
Biotech Growth makes 14-times return on Forte Biosciences accepting $2.2bn bid from Argenx SE
Biotech Growth (BIOG) has bagged its second bid for a company in a month with Forte Biosciences, a US immunological drug developer accounting for 3% o...
Investment company news brought to you by Citywire Financial Publishers Limited,
QuotedData by Marten & Co, Sharesify, and the armchair trader.
Data provided by Morningstar.
Company documents provided by FE fundinfo.
